K reports of America’s largest pharmaceutical companies show that they continue to avoid paying much, if any, U.S. corporate income tax.
With a vision to rank among the top 100 pharmaceutical companies globally, Grindeks continues to drive innovation, expand its reach, and strengthen its competitive edge in both regional and ...